Table 1 KEGG pathways unique to set 1
From: Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab
Pathway ID | Pathway name | Direction |
|---|---|---|
5146 | Amoebiasis | Up |
5100 | Bacterial invasion of epithelial cells | Up |
3320 | PPAR signaling pathway | Up |
512 | Mucin type O-Glycan biosynthesis | Up |
5416 | Viral myocarditis | Down |
5332 | Graft-versus-host disease | Down |
5322 | Systemic lupus erythematosus | Down |
5150 | Staphylococcus aureus infection | Down |
5145 | Toxoplasmosis | Down |
5144 | Malaria | Down |
5140 | Leishmaniasis | Down |
4940 | Type I diabetes mellitus | Down |
4916 | Melanogenesis | Down |
4710 | Circadian rhythm - mammal | Down |
4640 | Hematopoietic cell lineage | Down |
4612 | Antigen processing and presentation | Down |
4514 | Cell adhesion molecules (CAMs) | Down |
4145 | Phagosome | Down |
4144 | Endocytosis | Down |
4062 | Chemokine signaling pathway | Down |